Just catching up. The news today of adding Dr. Sonis is awesome and adds excellent credibility to the CTIX Scientific Advisory Board. I agree with many of the posts today that Leo is telling us investors that B-OM is working well and that they know it.
Question though: this isn't the big name respected board addition that Leo was referring to at the start of the year is it? I was under the impression that it was a board of directors addition, not the advisory board. Did I misunderstand or are there some more aces up Leo's sleeve?? I hate to admit, but I think that the market is going to somewhat ignore an addition to the scientific board. I think a big name on the directors board is more what the investment community is looking for. (Hey bashers I just did your job for you, you f#$kers, I'll expect my cut of the naked shorting now.)
That being said; Dr. Sonis is likely going to be a critical asset to CTIX with B-OM. I will not be surprised if having him in negotiations with potential partners for this drug will net CTIX multiples of dollars more that without him. Awesome news!